Welcome to the Entresto on-demand webinars page. Below you can access recordings from educational webinars that were hosted by experts in the field of heart failure and were organised by Novartis.
You will be required to register to watch the videos.
Five years of experience with Entresto (sacubitril/valsartan): looking back and moving forward – virtual symposium
A recording from the Novartis symposium at the British Society for Heart Failure’s 23rd annual autumn meeting, which took place virtually.
Prominent cardiologists Dr Patricia Campbell and Professor Mark Petrie exchange their experiences on using Entresto in the field of chronic heart failure.
Early initiation of Entresto® (sacubitril/valsartan): alter the cycle of readmission in patients with heart failure
Watch Dr Aaron Wong and Professor Jawad Khan present how early initiation of Entresto can alter the cycle of readmission in chronic HFrEF patients, looking at local data supporting this.
10th BSH Heart Failure Nurse and Allied Healthcare Professional Education Day webinar
Watch the Novartis virtual Meet the Expert and Symposium sessions from the 10th BSH Heart Failure Nurse and Allied Healthcare Professional Education Day on 21st May 2021.
British Cardiovascular Society Virtual Annual Conference 2021 webinar
A recording from the Novartis symposium at the British Cardiovascular Society’s annual conference which took place virtually in June 2021.
Watch Dr Patricia Campbell, Dr Parminder Chaggar and Dr Toomas Särev discuss how to initiate Entresto prior to hospital discharge, following haemodynamic stabilisation, in eligible patients with chronic HFrEF.
Treating the newly diagnosed chronic HFrEF patient – what should you prescribe?
In this Novartis sponsored webinar from 14th July 2021, Dr Patricia Campbell, Dr Katherine McCreary and Mandie Welch discuss the supporting evidence and real-world experience in initiating Entresto within this patient population.
Indication: Entresto is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction.1
BSH, British Society for Heart Failure; HFrEF, heart failure with reduced ejection fraction.
Reference
- Entresto Summary of Product Characteristics, 2021.